ABSTRACT-Sodium nitroprusside, nitroglycerin and carperitide (a-human ANP) all reduced mean blood pressure, but only carperitide increased the hematocrit in rats with bilateral renal artery and ureter-ligation. Nc-Monomethyl L-arginine, a selective inhibitor of nitric oxide synthesis, elevated the mean blood pressure but did not change the hematocrit significantly. These findings suggest that ANP has a physiological role in regulating circulatory blood volume distinct from that of NO, although both increase intracellular cyclic GMP in the vasculature. Nitric oxide (NO) is produced in vascular endothelial cells, and atrial natriuretic peptide (ANP) is produced in and released from atrial cells. Both NO and ANP re lax vascular smooth muscles (1, 2). ANP activates the particulate guanylate cyclase in smooth muscle (3), while NO activates soluble guanylate cyclase (4). Since ANP has a potent diuretic action (2), it has been sug gested that ANP might have a role in regulating blood volume (5). Several investigators have reported that administered atriopeptin (rat ANP) increases the hema tocrit in rats (6, 7). However, the increase in hemato crit has not been totally explained by fluid loss due to the diuretic action of ANP. Almedia et al. (6) have hypothesized that the rat ANP-induced increase in hematocrit may be due to an increase in the fluid efflux from capillaries, which thereby causes a decrease in plasma volume. On the other hand, kidney function has also been reported to be regulated by NO (8), but to our knowledge, the effect of NO on hematocrit is not known yet. To assess whether exogenous NO and ANP can modulate the hematocrit, we have examined the effect of NO-generating drugs and carperitide (a-hu man ANP) on the hematocrit by concomitantly moni toring arterial blood pressure and heart rate in anesthe tized rats.
Nitric oxide (NO) is produced in vascular endothelial cells, and atrial natriuretic peptide (ANP) is produced in and released from atrial cells. Both NO and ANP re lax vascular smooth muscles (1, 2) . ANP activates the particulate guanylate cyclase in smooth muscle (3) , while NO activates soluble guanylate cyclase (4) . Since ANP has a potent diuretic action (2) , it has been sug gested that ANP might have a role in regulating blood volume (5) . Several investigators have reported that administered atriopeptin (rat ANP) increases the hema tocrit in rats (6, 7) . However, the increase in hemato crit has not been totally explained by fluid loss due to the diuretic action of ANP. Almedia et al. (6) have hypothesized that the rat ANP-induced increase in hematocrit may be due to an increase in the fluid efflux from capillaries, which thereby causes a decrease in plasma volume. On the other hand, kidney function has also been reported to be regulated by NO (8) , but to our knowledge, the effect of NO on hematocrit is not known yet. To assess whether exogenous NO and ANP can modulate the hematocrit, we have examined the effect of NO-generating drugs and carperitide (a-hu man ANP) on the hematocrit by concomitantly moni toring arterial blood pressure and heart rate in anesthe tized rats.
Male Wistar rats weighing 200 290 g were used (Shizuoka Agr. Coop., Hamamatsu, Japan). Each of the drug-treatment groups consisted of 5 rats. Rats were anesthetized with urethane plus a -chloralose (500 mg/kg and 100 mg/kg, i.p., respectively). The bilateral renal arteries, veins and ureters exposed by a dorsal approach were ligated concomitantly. A tracheotomy was performed to keep good ventilation. Polyethylene catheters (PE 50) were inserted into the left juglar vein for infusion of drugs and into the right common carotid artery for measurement of systemic blood pressure and withdrawal of blood sample for determination of hemato crit. Blood pressure (BP) was measured by a pressure transducer (MPU-0.5A, Nihon Kohden, Tokyo), and heart rate (HR) was measured with a heart rate counter (AT-600T, Nihon Kohden) triggered by the BP pulse. Changes in BP and HR were continuously recorded on a polygraph recorder (RM-6200, Nihon Kohden). At first, the effect of physiological saline solution (vehicle) given intravenously in a volume of 80 p1/kg/min for 30 min was studied in all animals used, and then each of the test drugs was cumulatively in fused by increasing the concentration in a stepwise fashion at the same infusion speed as saline alone. Sodium nitroprusside (Nacalai Tesque, Kyoto), ni troglycerin (Nihon Kayaku, Tokyo), carperitide (recom binant a-human ANP; Suntory), and NG-monomethyl L-arginine acetate (Sigma, St. Louis) were used in the present study.
The results obtained were expressed as the mean ± S.E and analyzed with Dunnett's multiple range test us ing Stat View II (Abacus Concepts, Inc., Barkeley, CA) for the Macintosh Ilci (Apple Computer, Inc., Cupertino, CA). Mean blood pressure (MBP) before infusion of saline in each group receiving saline, sodium nitropusside (SNP), nitroglycerin (NTG), carperitide and Nc monomethyl-L-arginine acetate (L-NMMA) was 69 ± 4, 75 ± 6, 77 ± 2, 69 ± 5 and 84 ± 5 mmHg, respective ly; and HR was 365 ± 17, 384 ± 18, 407 ± 28, 386 ± 4 and 400 ± 15 beats/min, respectively. Figure 1 shows the time course of the effects of drugs used on MBP (left) and HR (right). Infusion of saline (control) caused no appreciable changes in MBP, but tended to decrease HR (Fig. 1A) . SNP at 1 and 3 ,ug/kg/min also significantly decreased MBP and tended to decrease HR (Fig. 1B) , while NTG has no such clear effects on MBP or HR. Carperitide elicited a significant de crease in MBP at 1 and 3 tug/kg/min and HR at 3 ,ug/kg/min (Fig. 1C) . Intravenous administration of 150 and 500,ug/kg/min L-NMMA, a NO synthase in hibitor (9, 10), elicited a significant increase in BP, but no change in HR (Fig. 1D) .
The hematocrit at 30 min after infusion of saline in each group for saline (control), SNP, NTG, carperitide and L-NMMA was 49 ± 1, 51 ± 1, 46 ± 2, 45 ± 2 and 47 ± 1%, respectively (Fig. 2 ). There were no signifi cant differences in the hematocrit among the groups. Saline infusion elicited an appreciable decrease in hematocrit. SNP and NTG (0.1 3 ,ug/kg) tended to decrease the hematocrit in a manner similar to the con trol ( Fig. 2A) . Carperitide (0.1 3 ,ug/kg/min) elicited an increase in hematocrit, and the values at 30 min after infusion of 0.3, 1 and 3 ,ug/kg/min were signifi cantly (P < 0.05 or P < 0.01) greater than the corre sponding value in the control group (Fig. 2B) . L NMMA (15 500 ,u g/kg/min) also tended to decrease the hematocrit to a lesser extent than the NO-produc ing compounds, but there was no significant difference as compared with the control (Fig. 2C) .
In previous studies, rat ANP increased the hemato crit value due to an increase in capillary permeability accompanied by a decrease in plasma volume (6, 7) . In the present study, carperitide (a-human ANP) induced an increase in hematocrit in the bilateral renal artery and ureter-ligated rats, indicating that exogenous ANP including carperitide alters extracellular fluid partition.
Like carperitide, organic nitrocompounds such as SNP and NTG decreased MBP; however, they did not alter the hematocrit. These results suggest that cyclic GMP production in the vasculature may not always lead to hematocrit alterations and that the increase in hematocrit is unlikely to be due to arterial vasodilation alone, because SNP did not increase the hematocrit.
Activation of particulate and soluble guanylate cyclases may have different functions in controlling fluid per meability.
It has been reported that ANP increases the he matocrit in nephrectomized rats. Trippodo and Barbee (7) have proposed that exogenous ANP alters the aver age whole-body capillary hydrostatic pressure in favor of facilitated filtration. Thus, it is plausible that reduc tion of the intravascular volume is involved in the carperitide-induced hematocrit increase.
The i.v.-bolus injection of L-NMMA, but not of D NMMA, elicited an increase in arterial blood pressure; this response was reversed by L-arginine in anesthetized guinea pigs and in both anesthetized and conscious rats (11) (12) (13) . These results indicate that basal NO produc tion is sufficient to modulate peripheral vascular resist ance. In the present study, intravenous infusion of L NMMA elicited a large and sustained increase in ar terial blood pressure, but did not cause a significant change in hematocrit. This finding implies that basal NO synthase activity may not be involved in regulating the fluid permeability.
It has been reported that plasma ANP levels are in creased in congestive heart failure and renal failure, and also increased in hypertensive rats such as spon taneous hypertensive rat (SHR) and Dahl salt-sensitive rat (2, 14) . NO synthesis may be promoted in stroke prone SHR (15) . On the other hand, ANP has a strong diuretic effect (2, 14) , but NO does not (8) . Taken together, ANP might be homeostatically released to regulate hemodynamics and plasma volume, and NO might be released to regulate hemodynamics without changing plasma volume.
In conclusion, exogenous human ANP (carperitide), like rat ANP, modulates plasma volume, but either endogenous or exogenous NO does not. NO may have a different physiological role from ANP, although both are endogenous vasorelaxants which act by increasing the cellular cyclic GMP level.
